Sandra Leung left the role of Executive Vice President, General Counsel at Bristol Myers Squibb on February 18, 2025, according to an SEC filing.
| Name | Sandra Leung |
|---|---|
| Role | Executive Vice President, General Counsel |
| Company | Bristol Myers Squibb |
| Industry | Pharmaceuticals |
| Location | Princeton, NJ |
| Move | Departure |
| Date | February 18, 2025 |
| Source | an SEC filing |
Sandra Leung notified Bristol Myers Squibb on February 14, 2025 of her intention to retire as Executive Vice President, General Counsel during 2025, remaining in place through a transition of her duties. (Source: an SEC filing.)
Other general counsel moves in February 2025
- Timothy Woods Named Chief Legal Officer of VestGen (February 28, 2025)
- Jay Reynardus Named General Counsel of EBG (February 28, 2025)
- Barbara Bispham Named General Counsel of Crescent Biopharma (February 28, 2025)
- Shirley Kuhlmann Steps Down as Executive Vice President, Chief Administrative Officer, General Counsel & Secretary of Collegium Pharmaceutical (February 27, 2025)
- Phillip Gillespie Named Chief Legal, Risk and Compliance Officer of Ascensus (February 26, 2025)
- Thomas Chabanis Named General Counsel of TISSIUM (February 25, 2025)
- Jennifer Kaplan Schott Named Executive Vice President, Chief Legal Officer of Sysco (February 25, 2025)
- Jorge Reynardus Named General Counsel of EBG (February 25, 2025)
Planning your own next move?
Read our guide to becoming a general counsel and the in-house counsel salaries guide.
Browse every appointment in the General Counsel Directory.
Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.
Does this information need updating? Email us at info@inhouseblog.com.